Our results of cumulative analyses further emphasize the importance of changes that occur simultaneously in cellular transport (p.Ser893Ala/Thr in ABCB1, c.-24C>T in ABCC2) and DNA repair systems (p.Lys751Gln in ERCC2) for the outcome of treatment in breast cancer patients. This evidence concerns the gene ERCC2 and breast cancer.